BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25706089)

  • 1. Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1.
    Manfra O; Van Craenenbroeck K; Skieterska K; Frimurer T; Schwartz TW; Levy FO; Andressen KW
    ACS Chem Neurosci; 2015 Jul; 6(7):1206-18. PubMed ID: 25706089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
    Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA
    Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
    Willins DL; Berry SA; Alsayegh L; Backstrom JR; Sanders-Bush E; Friedman L; Roth BL
    Neuroscience; 1999; 91(2):599-606. PubMed ID: 10366017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.
    Rauly-Lestienne I; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Cussac D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):93-105. PubMed ID: 17786406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preassociation between the 5-HT
    Ulsund AH; Dahl M; Frimurer TM; Manfra O; Schwartz TW; Levy FO; Andressen KW
    FASEB J; 2019 Mar; 33(3):3870-3886. PubMed ID: 30508496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors.
    Thomas DR; Middlemiss DN; Taylor SG; Nelson P; Brown AM
    Br J Pharmacol; 1999 Sep; 128(1):158-64. PubMed ID: 10498847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
    Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo 5-HT(6) receptor occupancy by antipsychotic drugs in the rat brain.
    Hirano K; Searle KL; Nasir S; Aw CC; Browne ER; Rutter AR
    Neurosci Lett; 2011 Oct; 503(3):240-3. PubMed ID: 21896308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907.
    Singh RK; Dai Y; Staudinger JL; Muma NA
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):651-65. PubMed ID: 18976543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
    Wood MD; Scott C; Clarke K; Cato KJ; Patel N; Heath J; Worby A; Gordon L; Campbell L; Riley G; Davies CH; Gribble A; Jones DN
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):445-52. PubMed ID: 16918396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
    Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
    Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
    Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D(3) receptors are down-regulated following heterologous endocytosis by a specific interaction with G protein-coupled receptor-associated sorting protein-1.
    Thompson D; Whistler JL
    J Biol Chem; 2011 Jan; 286(2):1598-608. PubMed ID: 21030592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
    Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
    Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro.
    Melkersson K
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):115-9. PubMed ID: 15013026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral pharmacology of olanzapine: a novel antipsychotic drug.
    Moore NA; Leander JD; Benvenga MJ; Gleason SD; Shannon H
    J Clin Psychiatry; 1997; 58 Suppl 10():37-44. PubMed ID: 9265915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation.
    Theisen FM; Haberhausen M; Firnges MA; Gregory P; Reinders JH; Remschmidt H; Hebebrand J; Antel J
    Pharmacogenomics J; 2007 Aug; 7(4):275-81. PubMed ID: 16983399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.